Sep 13, 2024 · Chorea that interferes with activities of daily living (eg, the ability to dress, eat, chew, or attend to personal hygiene effectively) likely requires treatment. Chorea can cause …

The VMAT-2 inhibitors are utilized for the management of chorea associated with Huntington Disease (HD) and for the management of tardive dyskinesia (TD). Tetrabenazine, the first …

Aug 23, 2023 · Tetrabenazine tablets are used to treat involuntary movements (chorea) caused by Huntington's disease, which is a rare, inherited disease that causes nerve cells in the brain …

Abstract Background Although tetrabenazine, a drug that depletes presynaptic dopamine by inhibiting vesicular monoamine transporter 2 (VMAT2), was approved by the U.S. Food and …

This open-label, single-arm study evaluates the safety and explores the efficacy of conversion from tetrabenazine to deutetrabenazine in patients with chorea associated with Huntington …

Dec 1, 2025 · Tetrabenazine is used to treat chorea (a movement disorder) that is caused by Huntington disease. Tetrabenazine works in the central nervous system (CNS) to prevent the …

Mar 7, 2025 · Overview: Tetrabenazine is a medicine used to treat chorea caused by Huntington’s disease. The medicine works to block certain chemicals in the brain, which helps cause less …

IN huNTINGToN’S DISEASE This is a summary of the American Academy of Neurology (AAN) guideline regarding pharmacologic treatment of chorea in Huntington’s disease (HD).

Medscape - Huntington disease dosing for Xenazine (tetrabenazine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and …

AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …